The targeted therapies erlotinib and cetuximab, in combination with standard chemotherapy regimens, are well tolerated and have very encouraging activity in recurrent/metastatic head and neck squamous cell carcinoma, according to two presentations at the American Society of Clinical Oncology (ASCO) 2007 Annual Meeting in Chicago.
Wound Management Following Facial Plastic Surgery
What If They Gave Universal Coverage and No Doctors Came?
The growing numbers of politicians and special interest and consumer groups pushing health insurance for all often neglect-and sometimes penalize-the people they need most for such plans to succeed: America’s physicians.
To Accredit or Not to Accredit?: Accreditation Soon May Be Required for In-Office CT Scanners: Part 2 of 3
By March 1, 2008, otolaryngologists offering point-of-care CT scanning-and who are UnitedHealthcare providers-must initiate accreditation of their diagnostic facilities.
Stereotactic Radiotherapy Treats Skull Base Tumors: Part 2 of
Stereotactic radiotherapy is increasingly gaining favor as an attractive alternative to conventional surgery of the skull base and head and neck.
Oral Cancer Screening: A Necessary Part of Any Exam
Oral screening exams are inexpensive, are easy to perform, and have the potential to reduce the annual global mortality for oral cancer by tens of thousands of people.
Lawyers Tell Physicians How to Protect Themselves from the Pitfalls of Employment
More often than not, today’s medical offices are businesses employing numerous staff people, as well as other physicians.
BPPV: State of the Art in Diagnosis And Treatment
Vertigo is a complaint that often causes patients to seek a consultation with an otolaryngologist.
Stereotactic Radiotherapy: A Growing Opportunity for Otolaryngologists: Part 1 of 2
Part 2 of this article will discuss treatment options for skull base tumors.
Ménière’s Disease: A Diagnosis of Exclusion with Controversial Therapies
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 104
- Next Page »